Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05983198
Title A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Novartis Investigative Site RECRUITING Dijon Cote D Or 21034 France Details
Novartis Investigative Site RECRUITING Clermont-Ferrand 63011 France Details
Novartis Investigative Site RECRUITING Lyon 69373 France Details
Novartis Investigative Site RECRUITING Nantes Cedex 1 44093 France Details
Novartis Investigative Site RECRUITING Saint Herblain 44805 France Details
Novartis Investigative Site RECRUITING Vandoeuvre 54511 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field